Evidence map›Paper›PMID 37187484›Full record

ArticleInfection and drug resistance2023

Surgical Resection to Treat a Japanese Patient with Pulmonary Coccidioidomycosis.

Takashi Abe, Fumihiro Yamaguchi, Shunsuke Sakakura, Yo Shiratori, Ayaka Mase, Toshitaka Funaki, Yoshito Kamio, Takashi Suzuki, Yusuke Shikama, Yasutaka Hoshino

Open access · goldAbstract readCase Reports
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Takashi Abe *Department of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Fumihiro Yamaguchi *Department of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.ORCID 0000-0003-1611-6991
Shunsuke SakakuraDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Yo ShiratoriDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Ayaka MaseDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Toshitaka FunakiDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Yoshito KamioDepartments of Thoracic Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
Takashi SuzukiDepartments of Thoracic Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
Yusuke ShikamaDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.ORCID 0000-0003-3776-8366
Yasutaka HoshinoDepartment of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan.
Showa University Fujigaoka Hospital · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coccidioidomycosis is an endemic disease that is particularly prevalent in the United States. However, its geographic distribution is becoming widespread. Here, we present a Japanese male who resided in the United States for 1 year, where he was diagnosed with pulmonary coccidioidomycosis that was accompanied by cavity formation. He did not tolerate antifungal therapy and consequently underwent partial resection of the upper lobe of his left lung upon his return to Japan. The patient's symptoms improved after surgery. The trend toward global networking and logistics means that a diagnosis of coccidioidomycosis should be considered in routine practice in nonendemic areas. Due to the rarity of surgical treatment for this disease, prolonged follow-up is necessary. During the last follow-up, the patient was symptom-free.

Indexed as

Coccidioides immitisCoccidioides posadasiicoccidioidomycosisendemic disease

Identifiers

PMID37187484
PMCPMC10178290
OpenAlexW4375867045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.